John Renger
CIK 1830363 · Chief Scientific Officer · last filed 2024-08-05
John Renger is a Chief Scientific Officer who has filed 22 SEC Form 4 insider transactions across 2 companies since 2020. Across all open-market trades the lifetime net is −$16.1M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
22
-$16.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Chief Scientific Officer | 8,531 | $44.96 | $383.6K | -$16.13M | 19 | 2024-02-08 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Chief Scientific Officer | — | $18.07 | — | $0 | 2 | 2021-02-05 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-05 | — | Disp (D) | −6,370 | $0 | |
| 2024-02-08 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | +2,859 | -$89.8K | EDGAR |
| 2024-01-23 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-08 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-03 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$560.9K | EDGAR |
| 2022-10-06 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$560.9K | EDGAR |
| 2022-08-12 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$1.86M | EDGAR |
| 2022-08-09 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$922.5K | EDGAR |
| 2022-07-22 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$662.5K | EDGAR |
| 2022-07-07 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$694.5K | EDGAR |